Product Library
Browse pharmaceutical products with CDE, DMF, and CEP registrations
Total Products
6,380
CDE Registered
2,513
DMF Registered
3,676
CEP Registered
806
Products starting with "S"
70 total, page 3 of 4| Product | CAS | CDE | DMF | CEP | Pattern | Action |
|---|---|---|---|---|---|---|
| Sitagliptin Phosphate Monohydrate, Process III | 654671-77-9 | 0 | 0 | 1 | CEP | View → |
| Simvastatin, Bha, Process II 辛伐他汀无润滑剂颗粒 | 79902-63-9 | 0 | 0 | 1 | CEP | View → |
| Sorafenib Tosilate, Micronised, Polymorphic Form I | 475207-59-1 | 0 | 0 | 1 | CEP | View → |
| Sodium Hyaluronate, Intrinsic Viscosity 2.3 M3/kg, By Fermentation, For Parenteral Administration Other Than Intra-articular Administration And Intra-ocular Use | 9067-32-7 | 0 | 0 | 1 | CEP | View → |
| Sodium Hyaluronate, Ha-ep 3.0 (intrinsic Viscosity: 2.7-3.6 M3/kg); From Fermentation; For Parenteral Administration Including Intra-articular Administration And Intra-ocular Use | 9067-32-7 | 0 | 0 | 1 | CEP | View → |
| Spectinomycin Dihydrochloride Pentahydrate, Jinxi | 22189-32-8 | 0 | 0 | 1 | CEP | View → |
| Spectinomycin Sulfate Tetrahydrate For Veterinary Use, Jinxi | 64058-48-6 | 0 | 0 | 1 | CEP | View → |
| Simvastatin, With Butylated Hydroxyanisole 0.010% 辛伐他汀无润滑剂颗粒 | 79902-63-9 | 0 | 0 | 1 | CEP | View → |
| Sodium Hyaluronate, Intrinsic Viscosity 1.8 M3/kg, By Fermentation, For Parenteral Administration Including Intra-articular Administration And For Intra-ocular Use | 9067-32-7 | 0 | 0 | 1 | CEP | View → |
| Sodium Hyaluronate, Intrinsic Viscosity 2.5 M3/kg, By Fermentation, For Parenteral Administration Including Intra-articular Administration And For Intra-ocular Use | 9067-32-7 | 0 | 0 | 1 | CEP | View → |
| Sodium Hyaluronate, Ha-e2.0 (intrinsic Viscosity 1.2-2.8 M3/kg), From Fermentation, For Parenteral Administration Other Than Intra-articular Administration And Intra-ocular Use | 9067-32-7 | 0 | 0 | 1 | CEP | View → |
| Sodium Hyaluronate, Intrinsic Viscosity 2.4 M3/kg, By Fermentation, For Parenteral Administration Including Intra-articular Administration And For Intra-ocular Use | 9067-32-7 | 0 | 0 | 1 | CEP | View → |
| Sodium Hyaluronate, Ha-ep 1.8 (intrinsic Viscosity: 1.6-2.2 M3/kg); From Fermentation; For Parenteral Administration Including Intra-articular Administration And Intra-ocular Use | 9067-32-7 | 0 | 0 | 1 | CEP | View → |
| Sodium Hyaluronate, Intrinsic Viscosity 0.6 M3/kg And 0.8 M3/kg, By Fermentation, For Parenteral Administration Including Intra-articular Administration And For Intra-ocular Use | 9067-32-7 | 0 | 0 | 1 | CEP | View → |
| Sodium Hyaluronate, Intrinsic Viscosity 3.8 M3/kg, By Fermentation, For Parenteral Administration Including Intra-articular Administration And For Intra-ocular Use | 9067-32-7 | 0 | 0 | 1 | CEP | View → |
| Sodium Hyaluronate, Intrinsic Viscosity 1.4 M3/kg And 1.0 M3/kg, By Fermentation, For Parenteral Administration Including Intra-articular Administration And For Intra-ocular Use | 9067-32-7 | 0 | 0 | 1 | CEP | View → |
| Simvastatin, Process II 辛伐他汀无润滑剂颗粒 | 79902-63-9 | 0 | 0 | 1 | CEP | View → |
| Simvastatin, Process II, With Butylated Hydroxyanisole 0.010% 辛伐他汀无润滑剂颗粒 | 79902-63-9 | 0 | 0 | 1 | CEP | View → |
| Sodium Hyaluronate, Intrinsic Viscosity 1.25 M3/kg, By Fermentation, For Parenteral Administration Including Intra-articular Administration And For Intra-ocular Use | 9067-32-7 | 0 | 0 | 1 | CEP | View → |
| Sodium Hyaluronate, Intrinsic Viscosity 1.66 M3/kg, 2.27 M3/kg, 3.30 M3/kg; From Fermentation; For Parenteral Administration Including Intra-articular Administration And Intra-ocular Use | 9067-32-7 | 0 | 0 | 1 | CEP | View → |